Peri-complication diagnosis of hepatitis C infection: Risk factors and trends over time
- PMID: 32956567
- DOI: 10.1111/liv.14670
Peri-complication diagnosis of hepatitis C infection: Risk factors and trends over time
Abstract
Background & aims: Hepatitis C virus (HCV) is a common and treatable cause of cirrhosis and its complications, yet many chronically infected individuals remain undiagnosed until a late stage. We sought to identify the frequency of and risk factors for HCV diagnosis peri-complication, that is within six months of an advanced liver disease complication.
Methods: This was a retrospective cohort study of Ontario residents diagnosed with chronic HCV infection between 2003 and 2014. HCV diagnosis peri-complication was defined as the occurrence of decompensated cirrhosis, hepatocellular carcinoma or liver transplant within ±6 months of HCV diagnosis. Multivariable logistic regression was used to identify risk factors for peri-complication diagnosis among all those diagnosed with HCV infection.
Results: Our cohort included 39,515 patients with chronic HCV infection, of whom 4.2% (n = 1645) were diagnosed peri-complication; these represented 31.6% of the 5,202 patients who developed complications in the follow-up period. Peri-complication diagnosis became more common over the study period and was associated with increasing age among baby boomers, alcohol use, diabetes mellitus, chronic HBV co-infection and moderate to high levels of morbidity. Female sex, immigrant status, having more previous outpatient physician visits, a previous emergency department visit, a history of drug use or mental health visits were associated with reduced risk of peri-complication diagnosis.
Conclusions: Over a quarter of HCV-infected patients with complications were diagnosed peri-complication. This problem increased over time, suggesting a need to further expand HCV screening.
Keywords: cirrhosis; screening; temporal trends; viral hepatitis.
© 2020 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Comment in
-
Delayed diagnosis and disparity in hepatitis C virus-infected immigrants in North America: A call for action.Liver Int. 2021 Feb;41(2):420. doi: 10.1111/liv.14709. Epub 2020 Nov 3. Liver Int. 2021. PMID: 33091237 No abstract available.
-
Peri-complication diagnosis of HCV among immigrants.Liver Int. 2021 Feb;41(2):421. doi: 10.1111/liv.14737. Epub 2020 Dec 12. Liver Int. 2021. PMID: 33222400 No abstract available.
References
REFERENCES
-
- Public Health Agency of Canada. Report on Hepatitis B and C in Canada: 2014. 2017; https://www.canada.ca/en/services/health/publications/diseases-condition....
-
- World Health Organization. Global Hepatitis Report. Geneva; 2017.
-
- Feld JJ, Liang TJ. Hepatitis C - identifying patients with progressive liver injury. Hepatology (Baltimore, MD). 2006;43(2 Suppl 1):S194-S206.
-
- Kwong JC, Ratnasingham S, Campitelli MA, et al. The impact of infection on population health: results of the Ontario burden of infectious diseases study. PLoS One. 2012;7(9):e44103.
-
- Afdhal N, Zeuzem S, Kwo P, et al. Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection. N Eng J Med. 2014;370(20):1889-1898.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
